ArticleNeuro-oncology advances
Utility of dynamic
Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Distinguishing early recurrence from pseudoprogression after chemoradiotherapy remains a major challenge in glioblastoma. Although Methods: Sixty-six patients with glioblastoma underwent FET-PET within 6 months of radiotherapy. Final diagnosis was determined by histopathology (n = 15) or predefined clinical endpoints (n = 51). Static metrics (SUV Results: Thirty-five patients (53%) had recurrence and 31 (47%) pseudoprogression. TAC morphology demonstrated the highest diagnostic accuracy (AUC 0.76; sensitivity 68.8%; specificity 94.7%; PPV 93.6%; NPV 72.9%), outperforming SUV Conclusions: Dynamic FET-PET improves diagnostic specificity and provides prognostic insight beyond static uptake metrics. TAC patterns offer a structured framework for improving diagnostic certainty and guiding therapeutic decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.